KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in IntangiblesChange in InventoryDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Net Income: 2018-2025

Historic Net Income for BioNTech SE (BNTX) over the last 7 years, with Sep 2025 value amounting to $91.3 million.

  • BioNTech SE's Net Income fell 30.31% to $91.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$516.0 million, marking a year-over-year decrease of 188.70%. This contributed to the annual value of -$710.9 million for FY2024, which is 171.03% down from last year.
  • As of Q3 2025, BioNTech SE's Net Income stood at $91.3 million, which was up 119.26% from -$474.1 million recorded in Q2 2025.
  • In the past 5 years, BioNTech SE's Net Income registered a high of $8.4 billion during Q3 2021, and its lowest value of -$865.6 million during Q2 2024.
  • Its 3-year average for Net Income is -$7.7 million, with a median of $91.3 million in 2025.
  • Per our database at Business Quant, BioNTech SE's Net Income skyrocketed by 13,561,721,438.29% in 2021 and then slumped by 138.63% in 2024.
  • Over the past 5 years, BioNTech SE's Net Income (Quarterly) stood at $7.2 billion in 2021, then slumped by 42.08% to $4.1 billion in 2022, then slumped by 77.48% to $934.5 million in 2023, then slumped by 60.79% to $366.4 million in 2024, then crashed by 30.31% to $91.3 million in 2025.
  • Its Net Income was $91.3 million in Q3 2025, compared to -$474.1 million in Q2 2025 and -$499.6 million in Q1 2025.